Search Results - "Horvath, Gyorgy"

Refine Results
  1. 1

    Cancer odor in the blood of ovarian cancer patients: a retrospective study of detection by dogs during treatment, 3 and 6 months afterward by Horvath, György, Andersson, Håkan, Nemes, Szilárd

    Published in BMC cancer (26-08-2013)
    “…In recent decades it has been noted that trained dogs can detect specific odor molecules emitted by cancer cells. We have shown that the same odor can also be…”
    Get full text
    Journal Article
  2. 2

    Characteristic odour in the blood reveals ovarian carcinoma by Horvath, György, Andersson, Håkan, Paulsson, Gunnar

    Published in BMC cancer (24-11-2010)
    “…Ovarian carcinoma represents about 4% of all cancers diagnosed in women worldwide. Mortality rate is high, over 50%, mainly due to late diagnosis. Currently…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Human Ovarian Carcinomas Detected by Specific Odor by Horvath, György, Järverud, Gunvor af Klinteberg, Järverud, Sven, Horváth, István

    Published in Integrative cancer therapies (01-06-2008)
    “…The high mortality rate associated with ovarian carcinoma is mainly owing to late diagnosis. It is thus essential to develop inexpensive and simple methods for…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors by Partheen, Karolina, Levan, Kristina, Österberg, Lovisa, Horvath, György

    Published in European journal of cancer (1990) (01-11-2006)
    “…It is difficult to predict the clinical outcome for patients with ovarian cancer. However, the use of biomarkers as additional prognostic factors may improve…”
    Get full text
    Journal Article
  7. 7

    A study of docetaxel weekly or every three weeks in combination with carboplatin as first line chemotherapy in epithelial ovarian cancer: Hematological and non-hematological toxicity profiles by SORBE, BENGT, GRAFLUND, MARIANNE, NYGREN, LISA, HORVATH, GYÖRGY

    Published in Oncology letters (01-04-2013)
    “…The purpose of this study was to compare the toxicity profiles of docetaxel administered on a weekly schedule and the standard three-week schedule in the…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Ergonomic Design Using Quality Function Deployment and Design of Experiments by Horvath, Peter Gyorgy, Kovacs, Zsolt, Denes, Levente

    Published in Forest products journal (01-07-2013)
    “…User needs relating to products are expressed in the language of customers. Designers are facing the challenge of answering the question of how relatively…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Specific Copy Number Alterations Associated with Docetaxel/Carboplatin Response in Ovarian Carcinomas by ÖSTERBERG, Lovisa, LEVAN, Kristina, PARTHEEN, Karolina, DELLE, Ulla, OLSSON, Björn, SUNDFELDT, Karin, HORVATH, György

    Published in Anticancer research (01-11-2010)
    “…The continued high recurrence and mortality rate in ovarian cancer is a significant problem and the major obstacle in the treatment of ovarian cancer patients…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Usefulness of Current Risk Groups in the Treatment of Surgically Staged Endometrial Carcinomas; A Population-based Study from Western Sweden by PAULSSON, Gunnar, GENELL, Anna, JAKOBSEN, Anne-Marie, HORVATH, György

    Published in Anticancer research (01-05-2009)
    “…Background: Endometrial carcinoma is the most common malignancy of the female genital tract and its incidence is increasing. However, treatment results have…”
    Get full text
    Journal Article
  15. 15

    mdr-1 Single Nucleotide Polymorphisms in Ovarian Cancer Tissue: G2677T/A Correlates with Response to Paclitaxel Chemotherapy by Green, Henrik, Soederkvist, Peter, Rosenberg, Per, Horvath, Gyoergy, Peterson, Curt

    Published in Clinical cancer research (01-02-2006)
    “…Purpose: P-glycoprotein, encoded by the mdr-1 gene, confers multidrug resistance to a variety of antineoplastic agents, e.g., paclitaxel. Recently, different…”
    Get full text
    Journal Article
  16. 16

    A grounded theory exploration of the first visit to a cancer clinic—strategies for achieving acceptance by Jakobsson, Sofie, Horvath, Gyorgy, Ahlberg, Karin

    “…The purpose of this study was to investigate cancer patients’ experiences of their first visit to a cancer clinic. Nine patients with various cancer diagnoses…”
    Get full text
    Journal Article
  17. 17

    Sequential topotecan and oral etoposide in recurrent ovarian carcinoma pretreated with platinum-taxane : Results from a multicenter phase I/II study by GRONLUND, Bo, ENGELHOLM, Svend A, HORVATH, Gyorgy, MÄENPÄÄ, Johanna, RIDDERHEIM, Mona

    Published in Cancer (01-04-2005)
    “…The objectives of this study were to determine the maximum tolerable dose (MTD), toxicity, efficacy, and feasibility of a sequential regimen of fixed-dose…”
    Get full text
    Journal Article
  18. 18

    Differential distribution of tocopherols and tocotrienols in photosynthetic and non-photosynthetic tissues by Horvath, György, Wessjohann, Ludger, Bigirimana, Joseph, Jansen, Marcel, Guisez, Yves, Caubergs, Roland, Horemans, Nele

    Published in Phytochemistry (Oxford) (01-06-2006)
    “…Tocopherols and tocotrienols are tocochromanols that differ with respect to the saturation state of their isoprenoid side chain. Tocopherols are found in…”
    Get full text
    Journal Article
  19. 19

    ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel by Gréen, Henrik, Söderkvist, Peter, Rosenberg, Per, Horvath, György, Peterson, Curt

    Published in Journal of pharmaceutical sciences (01-06-2008)
    “…P-glycoprotein (P-gp), encoded by the ABCB1 gene, confers multi-drug resistance to a variety of antineoplastic agents, for example, paclitaxel. Recently, the…”
    Get more information
    Journal Article
  20. 20

    Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas by Partheen, Karolina, Levan, Kristina, Österberg, Lovisa, Claesson, Ingela, Fallenius, Ghita, Sundfeldt, Karin, Horvath, György

    Published in International journal of cancer (01-11-2008)
    “…The mortality rate for patients with ovarian carcinomas is high and the available prognostic factors are insufficient. The use of biomarkers may contribute to…”
    Get full text
    Journal Article